AUSTIN, Texas — Rein Therapeutics (“Rein”) (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines in orphan pulmonary and fibrosis indications, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to LTI-03 for the treatment of idiopathic pulmonary fibrosis. Fast Track designation...

NEW YORK, NY — Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for safusidenib, the company’s investigational, oral, brain-penetrant selective inhibitor of mutant IDH1....

Boston, Mass. – Chronic kidney disease (CKD) is common among people newly diagnosed with pulmonary hypertension (PH), and kidney function may continue to decline as PH progresses, according to a large study. Researchers found that several measures of abnormal blood flow and pressure in the heart and lungs were associated...